Citation
Li, Yao-Hua, et al. "Matrix-assisted Laser Desorption/ionization Time-of-flight Mass Spectrometry Combined With Magnetic Beads for Detecting Serum Protein Biomarkers in Parkinson's Disease." European Neurology, vol. 65, no. 2, 2011, pp. 105-11.
Li YH, Wang J, Zheng XL, et al. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in parkinson's disease. Eur Neurol. 2011;65(2):105-11.
Li, Y. H., Wang, J., Zheng, X. L., Zhang, Y. L., Li, X., Yu, S., He, X., & Chan, P. (2011). Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in parkinson's disease. European Neurology, 65(2), 105-11. https://doi.org/10.1159/000323427
Li YH, et al. Matrix-assisted Laser Desorption/ionization Time-of-flight Mass Spectrometry Combined With Magnetic Beads for Detecting Serum Protein Biomarkers in Parkinson's Disease. Eur Neurol. 2011;65(2):105-11. PubMed PMID: 21273779.
TY - JOUR
T1 - Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in parkinson's disease.
AU - Li,Yao-Hua,
AU - Wang,Jian,
AU - Zheng,Xiao-Li,
AU - Zhang,Yan-Li,
AU - Li,Xin,
AU - Yu,Shun,
AU - He,Xin,
AU - Chan,Piu,
Y1 - 2011/01/27/
PY - 2010/11/03/received
PY - 2010/12/05/accepted
PY - 2011/1/29/entrez
PY - 2011/1/29/pubmed
PY - 2011/6/15/medline
SP - 105
EP - 11
JF - European neurology
JO - Eur Neurol
VL - 65
IS - 2
N2 - BACKGROUND: Biomarkers for neurodegenerative diseases are essential to facilitate disease diagnosis. Application of proteomics has greatly hastened the search for novel biomarkers. In this study, new potential biomarkers were discovered, and a diagnostic pattern was established for idiopathic Parkinson's disease (PD) by using proteomic technology. METHODS: Serum proteins from PD patients and controls were captured by magnetic bead-based weak cation exchange. The molecular weight of the proteins in bead-binding fraction was detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Biomarker Wizard 3.1 and Biomarker Patterns Software were used for data analysis and constructing a model of biomarkers. A blinded testing set was used to validate the model. RESULTS: A total of 17 discriminating m/z peaks related to PD were identified. The model based on the 5 biomarkers generated an excellent separation between PD and healthy controls with 98.36% for the sensitivity and 83.05% for the specificity. Blind test data demonstrated the model could recognize patients with PD with a sensitivity of 85.0% and a specificity of 70.0%. CONCLUSIONS: The preliminary data suggested a potential application of MALDI-TOF-MS combined with magnetic beads. The model comprising 5 promising biomarkers can differentiate individuals with PD and the healthy subjects precisely.
SN - 1421-9913
UR - https://www.unboundmedicine.com/medline/citation/21273779/Matrix_assisted_laser_desorption/ionization_time_of_flight_mass_spectrometry_combined_with_magnetic_beads_for_detecting_serum_protein_biomarkers_in_parkinson's_disease_
L2 - https://www.karger.com?DOI=10.1159/000323427
DB - PRIME
DP - Unbound Medicine
ER -